Since asthma is characterized by increased cellular senescence in bronchial fibroblasts and myofibroblasts33, the combined observations that modGinA resulted in decreased circulating IL-5 levels, and reduced pulmonary p16 expression in the senescence-induced mouse model suggest that modGinA could have potential therapeutic applications in chronic asthma. This evidence concerns the gene CDKN2A and asthma.